A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : sIg / surface immunoglobulin

[Related PubMed/MEDLINE]
Total Number of Papers: 357
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   sIg  (>> Co-occurring Abbreviation)
Long Form:   surface immunoglobulin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2016 IL-4 rescues surface IgM expression in chronic lymphocytic leukemia. BCR, CLL, IGHV, IL-4
2015 Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells. DC-SIGN, FL
2015 Sugar-coated signaling in follicular lymphoma. BCR, FL
2014 Inability of monoclonal anti-light chain antibody to detect clonal B-cells in a patient with follicular lymphoma by multicolor flow cytometry. BM
2014 The role of immunophenotyping in differential diagnosis of chronic lymphocytic leukemia. CLL, MBCN
2014 Variant B cell receptor isotype functions differ in hairy cell leukemia with mutated BRAF and IGHV genes. BCR, HCL
2014 [Pathologic diagnosis of mature B-cell lymphoma]. Bcl, FCM, IHC
2013 MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia. BCR, CLL, IGHV, miRNAs, ZAP-70
2012 Comparative study of the plasma globulin level, CD21(-) B-cell counts and FOXP3 mRNA expression level in CD4(+) T-cells for different clinical stages of feline immunodeficiency virus infected cats. AC, ARC, FIV, FOXP3, SPF
10  2011 Burkitt's leukemia with an atypical immunophenotype: report of a case and review of literature. BL, FAB, pre-B ALL, TdT
11  2010 Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia. AID, CLL, CSR, Ig, SHM
12  2008 Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. BCR, CLL, ERK, MAP, NFAT
13  2007 The normal counterpart to the chronic lymphocytic leukemia B cell. CLL
14  2006 Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity. CR2, FDC
15  2006 Ligand-independent signaling during early avian B cell development. ---
16  2006 Surface immunoglobulin positive lymphoblastic leukemia in adults; a genetic spectrum. MLL
17  2005 Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line. B-CLL, BCR
18  2005 Secretory immunoglobulin A obtained from pooled human colostrum and milk for oral passive immunization. ---
19  2005 Surface and cytoplasmic immunoglobulin expression in B-cell chronic lymphocytic leukemia (CLL). cIg, CLL
20  2005 Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas. BCR, EBV, GC, HL, LCLs, PTLD, RT-PCR
21  2004 An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10. BV-MCL, MCL
22  2004 Carbamazepine-induced IgG1 and IgG2 deficiency associated with B cell maturation defect. CBZ
23  2004 Complex formation of CD23/surface immunoglobulin and CD23/CD81/MHC class II on an EBV-transformed human B cell line and inferable role of tetraspanin. EBV
24  2004 Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors. B-CLL, BCR, EGFP, HSPG, rAAV, ZAP-70
25  2004 Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch. AID, GC, HCL
26  2004 HBL-3 cell line, derived from precursor B-cell lymphoblastic leukemia, lacks somatic hypermutation of immunoglobulin heavy chain variable region genes. pB-ALL, SM
27  2004 Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients. ALL, FCI, pB, TdT
28  2004 Surface immunoglobulin-deficient Epstein-Barr virus-infected B cells in the peripheral blood of pediatric solid-organ transplant recipients. EBV, PTLD
29  2004 The avian B-cell receptor complex: distinct roles of Igalpha and Igbeta in B-cell development. ---
30  2003 Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone. BCLPDs, CLL, WBC
31  2003 Proliferative assays for B cell function. LPS
32  2003 Specific destruction of hybridoma cells by antigen-toxin conjugates demonstrate an efficient strategy for targeted drug therapy in leukemias of the B cell lineage. DNP-RTA, Ig, LTCs
33  2002 Cell surface immunoglobulin receptors in B cell development. ---
34  2002 Defective assembly of the B-cell receptor chains accounts for its low expression in B-chronic lymphocytic leukaemia. B-CLL, BCR
35  2002 Distinct patterns of mitogen-activated protein kinase phosphorylation and Epstein-Barr virus gene expression in Burkitt's lymphoma cell lines versus B lymphoblastoid cell lines. BLCLs, EBV, LCLs, MAPK
36  2002 Immunophenotype does not correlate with lymph node histology in chronic lymphocytic leukemia/small lymphocytic lymphoma. CLL/SLL, LNs, PCs
37  2002 Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B-cell lymphoma. ---
38  2002 Primary cutaneous lymphoblastic lymphoma presenting in an 8-week old infant. LBL
39  2002 The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis. Ab, B-CLL, BCR, ER, ITAM, SLVLs
40  2001 Burkitt's acute lymphoblastic leukaemia transformation after myelodysplastic syndrome. ALL, HLA, MDS
41  2001 Lymphokine dependence of STAT3 activation produced by surface immunoglobulin cross-linking and by phorbol ester plus calcium ionophore treatment in B cells. ---
42  2001 Ontogeny of pig discrete Peyer's patches: expression of surface antigens. MHC, PP, SLA
43  2000 Cloning non-transformed sheep B cells. HC, LC
44  2000 Early increase of peripheral B cell levels in kidney transplant recipients with CMV infection or reactivation. CMV, spot-forming
45  2000 Receptor-specific regulation of B-cell susceptibility to Fas-mediated apoptosis and a novel Fas apoptosis inhibitory molecule. FAIM, IL-4R
46  2000 The effects of allopurinol on immune function in normal BALB/c and SCID mice. AL, IgG, OVA, SCID, XO
47  1999 Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. ALL
48  1999 Characterization of a surface membrane molecule expressed by natural killer cells in most inbred mouse strains: monoclonal antibody C9.1 identifies an allelic form of the 2B4 antigen. NK
49  1999 FcgammaRIIb modulation of surface immunoglobulin-induced Akt activation in murine B cells. PtdIns 3,4,5-P3, PtdIns 3-kinase, SHIP
50  1999 Primary large cell lymphoma of the mediastinum. ---
51  1998 Antigen receptor cross-linking by anti-immunoglobulin antibodies coupled to cell surface membrane induces rapid apoptosis of normal spleen B cells. ---
52  1998 Biotin deficiency induces changes in subpopulations of spleen lymphocytes in mice. ---
53  1998 CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 cases. CLL
54  1998 Clinical utility of flow cytometry in the chronic lymphoid leukemias. CLL
55  1998 MAPkinase: a second site of G-protein regulation of B-cell activation via the antigen receptors. MAP kinase
56  1998 Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications. BM, cIg, MM, PB, PC, PCR
57  1998 Surface immunoglobulin light chain-positive acute lymphoblastic leukemia of FAB L1 or L2 type: a report of 6 cases in adults. ALL, FAB, TdT
58  1997 Clinical correlations of immunophenotypic variations and the presence of trisomy 12 in B-cell chronic lymphocytic leukemia. FISH, HC, LC
59  1997 Co-ligation of the antigen and Fc receptors gives rise to the selective modulation of intracellular signaling in B cells. Regulation of the association of phosphatidylinositol 3-kinase and inositol 5'-phosphatase with the antigen receptor complex. FcR
60  1997 Detection of proviral DNA of bovine leukaemia virus in cattle by a combination of in-situ hybridization and the polymerase chain reaction. BLV, EBL, ISH, PCR, PL, TAA
61  1997 Effect of B-cell receptor engagement on CD40-stimulated B cells. BCR, IgG, IL-10, IL-2, mAb, SA
62  1997 Follicular lymphoma immunoglobulin kappa light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains. CDRs, FWRs, PCR
63  1997 Lymphoma with multi gene rearrangement on the level of immunoglobulin heavy chain, light chains, and T-cell receptor beta chain. Ig, LN, TCR
64  1996 B cell hybridoma presents both B-cell and T-cell epitopes for stimulating antibody production via CD23 pathway. ---
65  1996 B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. ---
66  1996 Coexpression of cell-surface immunoglobulin (sIg), terminal deoxynucleotidyl transferase (TdT) and recombination activating gene 1 (RAG-1): two cases and derived cell lines. B-ALL, RAG1, TdT
67  1996 Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40. CAK, CDK, CKI
68  1996 Do myelomatous plasma cells really express surface immunoglobulins? MESF, PC
69  1996 Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia. B-CLL, LC
70  1996 Ligation of CD40 with soluble CD40 ligand reverses anti-immunoglobulin-mediated negative signalling in murine B lymphoma cell lines but not in immature B cells from neonatal mice. CD40L, LPS
71  1996 Mitogenic effect of HIV-infected human T cell lines on mouse B cells mediated by surface immunoglobulin. ---
72  1996 Oxidative stress triggers tyrosine phosphorylation in B cells through a redox- and inflammatory cytokine-sensitive mechanism. anti-IgM, PTK, sIgM
73  1996 Signaling pathways for antigen receptor-mediated induction of transcription factor CREB in B lymphocytes. CaM kinase II, PKA, PKC
74  1995 A role for calcitonin gene related peptide (CGRP) in the regulation of early B lymphocyte differentiation. CGRP, LPS
75  1995 Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation. B-CLL, LL, PL
76  1995 CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. FasL, HEL, MHC, TCR
77  1995 Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40. BL, cAMP, EBV, FM, GC, PGE2
78  1995 Engagement of CD20 suppresses apoptosis in germinal center B cells. GC, mAb
79  1995 Inhibitory effect of c-fos overexpression on B cell proliferative responses to membrane IGM cross-linking. IFN
80  1995 Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. I-kappaB, NF-kappaB
81  1994 Activation of AP-1 in primary B lymphocytes by surface immunoglobulin requires de novo Jun-B synthesis. ---
82  1994 Co-stimulation by anti-immunoglobulin is required for B cell activation by CD40Llow T cells. mAb, MHC, TCR, Th
83  1994 Cytoplasmic and surface membrane phenotypic markers in cells of B cell chronic lymphocytic leukemia. B-CLL, CyIg, MR
84  1994 Deregulated expression of c-fos disturbs proliferative responses of B cells to sIg cross-linking. ---
85  1994 Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody. CLL, CLL/PL, PLL
86  1994 Differentiation analysis of bovine T-lymphosarcoma. SBL, TCR
87  1994 Enhanced in vitro human immunodeficiency virus type 1 replication in B cells expressing surface antibody to the TM Env protein. HIV-1
88  1994 Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukemia: correlation with disease status and neoplastic phenotype. B-CLL, IF, PB
89  1994 Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. TCDD
90  1994 Inhibition of tumor cell growth by a human B-cell line. EBV
91  1994 Interleukin-2 (IL-2) production by human B-cell line. IL-2, rIL-2
92  1994 New cell line from hairy-cell leukaemia producing interleukin-6 after Epstein-Barr virus immortalization. cIg, EBV, HCL, IL-6
93  1994 Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes. IL-4
94  1994 Protein tyrosine kinases couple the surface immunoglobulin of germinal center B cells to phosphatidylinositol-dependent and -independent pathways of rescue from apoptosis. AgR, BH, GC, PI, PTK
95  1994 Protein-tyrosine kinase activity tightly associated with human type II Fc gamma receptors. PTK
96  1994 The V(D)J recombination in acute lymphoid leukemias: a short review. ---
97  1993 Age-related alterations in the activation and expression of phosphotyrosine kinases and protein kinase C (PKC) among human B cells. PKC, PTK, SAC
98  1993 Antigen-induced B lymphocyte activation involves the p21ras and ras.GAP signaling pathway. AgR
99  1993 B cell development in mice with a defective lambda 5 gene. ---
100  1993 B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. ---